http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5580736-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-064 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M15-0028 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2005-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77b0a2003803afe9fea88a16ac059c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b9ecebdf08d1c97f474db7fd97dbb3 |
| publicationDate | 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-5580736-A2 |
| titleOfInvention | NEW PULVERULENT FORMULATION CONTAINING INHALATION TIOTROPIO DESTI NADA |
| abstract | 1.- Inhalation powder containing 0.001 to 3% of tiotropium in admixture with a physiologically safe adjuvant substance, characterized in that the adjuvant substance has an average particle size of 10-50 µm, a fine portion of 10% of 0, 5 to 6 µm, as well as a specific surface area of 0.1 to 2 m2 / g.2.- Powder for inhalation according to claim 1, characterized in that the tiotropium is contained in the form of its chloride, bromide, iodide, methanesulfonate or para-toluene sulphonate. 3. Powder for inhalation according to claim 1 or 2, characterized in that the physiologically safe adjuvant substance is selected from the set consisting of monosaccharides, disaccharides, oligo- and poly-saccharides , the polyalcohols, or also the salts.4.- Powder for inhalation according to claim 3, characterized in that the physiologically safe adjuvant substance is selected from the set consisting of d and glucose, arabinose, lactose, sucrose, maltose and trehalose, possibly in the form of their hydrates. 5. Use of a powder for inhalation according to one of claims 1 to 4 for the preparation of a medicament for the treatment of diseases. of the respiratory tract, in particular to the treatment of COPD and / or asthma. 6.- Capsules containing a powder for inhalation according to one of claims 1 to 4.7.- Capsules according to claim 6, characterized in that The material of the capsules consists of a synthetic plastic material. 8. Capsules according to claim 7, characterized in that the material of the capsules is selected from the set consisting of a polymer of polyethylene, polycarbonate, polyester, polypropylene and poly (ethylene terephthalate) .9.- Capsules according to one of claims 6 to 8, characterized in that they contain approximately 1 to 20 mg of the inhalation powder tion according to one of claims 1 to 4.10.- Inhalation kit consisting of a capsule according to one of claims 6 to 9 and an inhaler, which can be used for the application of inhalation powders from capsules containing powders. |
| priorityDate | 2002-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.